US backs Moderna vaccine project with nearly $ 1 billion
Moderna said on Monday that he had launched an advanced stage trial supported by the US government to evaluate his COVID-19 vaccine candidate in about 30,000 adults who do not suffer from the respiratory disease caused by the novel coronavirus.
Shares of Cambridge, MA-based Moderna rose 11% to $ 81.31 before the bell.
The trial, named COVE, is the first to be implemented as part of the U.S. government’s Operation Warp Speed, which aims to accelerate the development, manufacture and distribution of COVID therapeutics and vaccines -19.
The federal government is backing Moderna’s vaccine project with nearly $ 1 billion and has chosen it as one of the first to undertake large-scale human trials.
The primary focus of the study will be the prevention of symptomatic disease of COVID-19, the company said.
(Except for the title, this story was not edited by GalacticGaming staff and is posted from a syndicated feed.)
